Molecular markers demonstrate diagnostic and prognostic value in the evaluation of myelodysplastic syndromes in cytopenia patients

被引:3
|
作者
He, Rong [1 ]
Chiou, Jonathan [2 ]
Chiou, Allison [3 ]
Chen, Dong [1 ]
Chen, Constance P. [4 ]
Spethman, Caroline [5 ]
Bessonen, Kurt R. [1 ]
Oliveira, Jennifer L. [1 ]
Nguyen, Phuong L. [1 ]
Reichard, Kaaren K. [1 ]
Hoyer, James D. [1 ]
Althoff, Simon D. [1 ]
Roh, Dana J. [1 ]
Miller, Mechelle A. [1 ]
Yuan, Ji [1 ]
Olteanu, Horatiu [1 ]
Begna, Kebede [6 ]
Tefferi, Ayalew [6 ]
Alkhateeb, Hassan [6 ]
Patnaik, Mrinal M. [6 ]
Litzow, Mark R. [6 ]
Al-Kali, Aref [6 ]
Viswanatha, David S. [1 ]
机构
[1] Mayo Clin, Coll Med, Div Hematopathol, Rochester, MN 55905 USA
[2] Dartmouth Coll, Hanover, NH USA
[3] Wellesley Coll, Wellesley, MA USA
[4] Univ Notre Dame, Coll Sci, Notre Dame, IN 46556 USA
[5] Univ Nebraska, Sch Med, Omaha, NE 68198 USA
[6] Mayo Clin, Coll Med, Div Hematol, Rochester, MN USA
关键词
CLONAL HEMATOPOIESIS; MUTATIONS; MDS; RISK;
D O I
10.1038/s41408-022-00612-w
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:4
相关论文
共 50 条
  • [41] Improving Prognostic Tools for Patients With Myelodysplastic Syndromes
    Garcia-Manero, Guillermo
    MAYO CLINIC PROCEEDINGS, 2018, 93 (10) : 1340 - 1342
  • [42] Complex karyotype in myelodysplastic syndromes: Diagnostic procedure and prognostic susceptibility
    Shahjahani, Mohammad
    Hadad, Elham Homaei
    Azizidoost, Shirin
    Nezhad, Kowsar Chenani
    Shahrabi, Saeid
    ONCOLOGY REVIEWS, 2019, 13 (01) : 30 - 36
  • [43] Promoter hypermethylation analysis in myelodysplastic syndromes: Diagnostic & prognostic implication
    Solomon, P. R.
    Munirajan, A. K.
    Tsuchida, Nobuo
    Muthukumarasamy, Kottampatti
    Rathinavel, Andiappan
    Selvam, G. S.
    Shanmugam, G.
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2008, 127 (01) : 52 - 57
  • [44] Prognostic and diagnostic value of hemostatic markers in patients at risk of stroke
    Cote, R
    Wolfson, C
    Solymoss, S
    Mackey, A
    Jacques, L
    Simard, D
    Rouah, F
    STROKE, 2000, 31 (01) : 326 - 326
  • [45] Diagnostic and prognostic significance of cytogenetics in adult primary myelodysplastic syndromes
    Jotterand, M
    Parlier, V
    LEUKEMIA & LYMPHOMA, 1996, 23 (3-4) : 253 - 266
  • [46] Evaluation of the Prognostic Significance of Eosinophilia and Basophilia in a Larger Cohort of Patients With Myelodysplastic Syndromes
    Wimazal, Friedrich
    Germing, Ulrich
    Kundi, Michael
    Noesslinger, Thomas
    Blum, Sabine
    Geissler, Philipp
    Baumgartner, Christian
    Pfeilstoecker, Michael
    Valent, Peter
    Sperr, Wolfgang R.
    CANCER, 2010, 116 (10) : 2372 - 2381
  • [47] PROGNOSTIC VALUE OF THE DUSSELDORF-SCORE IN 735 UNTREATED PATIENTS WITH PRIMARY MYELODYSPLASTIC SYNDROMES
    GERMING, U
    GATTERMANN, N
    RUNDE, V
    HEYLL, A
    JAEGER, M
    SCHNEIDER, W
    AUL, C
    BLOOD, 1994, 84 (10) : A314 - A314
  • [48] Tumours markers, prognostic and diagnostic value
    Magni, Mariapia Viola
    CURRENT OPINION IN BIOTECHNOLOGY, 2011, 22 : S17 - S17
  • [49] MECHANISMS AND PROGNOSTIC VALUE OF CELL-KINETICS IN THE MYELODYSPLASTIC SYNDROMES
    DORMER, P
    HERSHKO, C
    WILMANNS, W
    BRITISH JOURNAL OF HAEMATOLOGY, 1987, 67 (02) : 147 - 152
  • [50] Prognostic value of cell cultures in 100 cases of myelodysplastic syndromes
    Del Cañizo, MC
    Mota, A
    Malheiro, MI
    Matos, E
    Galende, J
    Del Cañizo, MC
    Ortuño, F
    San Miguel, JF
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 341 - 341